drugset / Trial / NCT00693693

Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis

NCT00693693

Phase 4 Completed 26 enrolled Wake Forest University
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this research study is to better understand adherence to Locoid when people use it to treat atopic dermatitis.

Timeline

Start
2006-11
Primary completion
2008-09
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrocortisone Butyrate Unknown 0.1 % Topical

Indications